Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B.
Katsuyuki FukutakeKanae TogoLinghua XuLeona E MarksonJosé Maria Jimenez AlvirIan WinburnToshiyuki KarumoriPublished in: Journal of blood medicine (2023)
In the real-world setting in Japan, medical expenditures and the proportion of patients prescribed EHL FIX concentrates for the treatment of hemophilia B have increased.